| Date Filed | Type | Description |
| 10/03/2023 |
4
| Subramanian Sanjay (SVP, CFO) has filed a Form 4 on Inozyme Pharma, Inc.|
Txns:
| Granted 2,319 shares
@ $3.57, valued at
$8.3k
|
|
| 04/04/2023 |
4
| Subramanian Sanjay (SVP, CFO) has filed a Form 4 on Inozyme Pharma, Inc.|
Txns:
| Granted 979 shares
@ $2.21, valued at
$2.2k
|
|
| 03/27/2023 |
4
| Subramanian Sanjay (SVP, CFO) has filed a Form 4 on Inozyme Pharma, Inc.|
Txns:
| Granted 135,000 options to buy
@ $3.3, valued at
$445.5k
|
|
| 04/20/2022 |
4
| Subramanian Sanjay (SVP, CFO) has filed a Form 4 on Inozyme Pharma, Inc.|
Txns:
| Bought 27,100 shares
@ $3.69, valued at
$100k
|
|
| 03/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/22/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/05/2022 |
4
| Subramanian Sanjay (CFO) has filed a Form 4 on Ocugen, Inc.|
Txns:
| Granted 125,534 shares
@ $0
Granted 454,007 options to buy
@ $4.72, valued at
$2.1M
|
|
| 12/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2021 |
4
| Subramanian Sanjay (CFO) has filed a Form 4 on Ocugen, Inc.|
Txns:
| Granted 35,560 options to buy
@ $0 |
|
| 10/27/2021 |
4
| Subramanian Sanjay (CFO) has filed a Form 4 on Ocugen, Inc.|
Txns:
| Sold 10,000 shares
@ $11.07, valued at
$110.7k
|
|
| 10/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/16/2021 |
4
| Subramanian Sanjay (CFO) has filed a Form 4 on Ocugen, Inc.|
Txns:
| Sold 31,086 shares
@ $6.7, valued at
$208.3k
Exercised 31,086 options to buy
@ $0.34, valued at
$10.6k
|
|
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2021 |
4
| Subramanian Sanjay (CFO) has filed a Form 4 on Ocugen, Inc.|
Txns:
| Exercised 35,591 options to buy
@ $0.51, valued at
$18.2k
|
|
| 01/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/07/2020 |
4
| Subramanian Sanjay (CFO) has filed a Form 4 on Ocugen, Inc.|
Txns:
| Granted 369,256 options to buy
@ $0.34, valued at
$125.5k
|
|
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/26/2019 |
4
| Subramanian Sanjay (CFO) has filed a Form 4 on Ocugen, Inc.|
Txns:
| Bought 5,000 shares
@ $0.28, valued at
$1.4k
|
|